Alamo logo

Alamo

ALG | NYSE
Chart Builder DCF Calculator
$136.09
-$2.83 (-2.04%)
At close: Nov 16, 2026, 4:00 PM ET
$136.09
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
-2.04%

Rating

Updated: Nov 16, 2026
37.1
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #647/882 (Top 73%)

Key Statistics

Market Data

Market Cap $1.66B
1D Range
135.65 139.45
52W Range
133.70 218.47

Valuation (TTM)

PE 21.23
PB 1.40
EV/EBITDA 8.57

Valuation (NTM)

Forward PE 14.29
Forward PEG 16.84
Price Target $161.00
Loading financial charts...

Profile

Alamo Group Inc. is a global enterprise specializing in the design, production, distribution, and servicing of equipment crucial for managing vegetation and maintaining public and private infrastructu...

Employees 3,800
IPO Date Mar 19, 1993
Fiscal Year January - December

Latest News

What Alamo Group (ALG) Said on Its Q3 Earnings Call

14 days ago · marketbeat.com

What Alamo Group (ALG) Said on Its Q3 Earnings Call
Alamo Group Inc. (ALG) Q3 2026 Earnings Call Transcript

14 days ago · seekingalpha.com

Alamo Group Inc. (ALG) Q3 2026 Earnings Call Transcript
Alamo Group (ALG) Q3 Earnings and Revenues Lag Estimates

14 days ago · zacks.com

Alamo Group (ALG) Q3 Earnings and Revenues Lag Estimates
ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER 2026 AND STRENGTHENS ITS INDUSTRIAL PORTFOLIO

14 days ago · prnewswire.com

ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER 2026 AND STRENGTHENS ITS INDUSTRIAL PORTFOLIO
Implied Volatility Surging for Alamo Group Stock Options

26 days ago · zacks.com

Implied Volatility Surging for Alamo Group Stock Options
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

3 months ago · globenewswire.com

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript
Alamo Group Q2 Earnings Call Highlights

3 months ago · marketbeat.com

Alamo Group Q2 Earnings Call Highlights
Alamo Group (ALG) Tops Q2 Earnings and Revenue Estimates

4 months ago · zacks.com

Alamo Group (ALG) Tops Q2 Earnings and Revenue Estimates
ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2026

4 months ago · prnewswire.com

ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2026

Earnings

Latest Earnings
Nov 2, 2026
EPS
$2.06
Miss -21.37%
REV
$403.14M
Miss -7.77%
Next Earnings
Mar 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Hold
Price Target
$161.00
Upside
+18.30%
Buy (0)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.